674
T.-S. Kim et al.
CLUSTER
(3) (a) Chhabra, S. R.; Harty, C.; Hooi, D. S. W.; Daykin, M.;
Williams, P.; Telford, G.; Pritchard, D. I.; Bycroft, B. W.
J. Med. Chem. 2003, 46, 97. (b) Geske, G. D.; O’Neill, J. C.;
Blackwell, H. E. ACS Chem. Biol. 2007, 2, 315.
(7) (a) Corey, E. J.; Xu, F.; Noe, M. C. J. Am. Chem. Soc. 1997,
119, 12414. (b) Park, H.-g.; Jeong, B.-S.; Yoo, M.-S.; Lee,
J.-H.; Park, M.-K.; Lee, Y.-J.; Kim, M.-J.; Jew, S.-s. Angew.
Chem. Int. Ed. 2002, 41, 3036. (c) Jew, S.-s.; Yoo, M.-S.;
Jeong, B.-S.; Park, H.-g. Org. Lett. 2002, 4, 4245. (d) Ooi,
T.; Kameda, M.; Maruoka, K. J. Am. Chem. Soc. 2003, 125,
5139.
(8) Terashima, S.; Achiwa, K.; Yamada, S.-i. Chem. Pharm.
Bull. 1965, 13, 1399.
(9) Procopiou, P. A.; Ahmed, M.; Jeulin, S.; Perciaccante, R.
Org. Biomol. Chem. 2003, 1, 2853.
(c) Kaufmann, G. F.; Sartorio, R.; Lee, S.-h.; Mee, J. M.;
Altobell, L. J. III; Kujawa, D. P.; Jeffries, E.; Clapham, B.;
Meijler, M. M.; Janda, K. D. J. Am. Chem. Soc. 2006, 128,
2802. (d) Geske, G. D.; O’Neill, J. C.; Miller, D. M.;
Mattmann, M. E.; Blackwell, H. E. J. Am. Chem. Soc. 2007,
129, 13613.
(4) (a) Schollkopf, U.; Lonsky, R. Synthesis 1983, 675.
(b) Seebach, D.; Aebi, J. D.; Naef, R.; Weber, T. Helv. Chim.
Acta 1985, 68, 144. (c) Smith, A. B. III; Pastemak, A.;
Yokoyama, A.; Hirschmann, R. Tetrahedron Lett. 1994, 35,
8977. (d) Ayoub, M.; Chassaing, G.; Loffet, A.; Lavielle, S.
Tetrahedron Lett. 1995, 36, 4069. (e) Berkowitz, D. B.;
McFadden, J. M.; Sloss, M. K. J. Org. Chem. 2000, 65,
2907.
(5) (a) Jew, S.-s.; Lee, Y.-J.; Lee, J.; Kang, M. J.; Jeong, B.-S.;
Lee, J.-H.; Yoo, M.-S.; Kim, M.-J.; Choi, S.-h.; Ku, J.-M.;
Park, H.-g. Angew. Chem. Int. Ed. 2004, 43, 2382. (b) Park,
H.-g.; Lee, J.; Kang, M. J.; Lee, Y.-J.; Jeong, B.-S.; Lee,
J.-H.; Yoo, M.-S.; Kim, M.-J.; Choi, S.-h.; Jew, S.-s.
Tetrahedron 2004, 60, 4243. (c) LeeY, j.; Lee, J.; Kim,
M.-j.; Kim, T.-S.; Park, H.-g.; Jew, S.-s. Org. Lett. 2005, 7,
1557. (d) LeeY, j.; Lee, J.; Kim, M.-j.; Jeong, B.-S.; Lee,
J.-H.; Kim, T.-S.; Ku, J.-M.; Park, H.-g.; Jew, S.-s. Org. Lett.
2005, 7, 3207. (e) Lee, J.; Lee, Y.-I.; Kang, M. J.; LeeY, j.;
Jeong, B.-S.; Lee, J. H.; Kim, M.-j.; Choi, J.-y.; Ku, J.-M.;
Park, H.-g.; Jew, S.-s. J. Org. Chem. 2005, 70, 4158.
(f) Kim, T.-S.; LeeY, j.; Jeong, B.-S.; Park, H.-g.; Jew, S.-s.
J. Org. Chem. 2006, 71, 8276.
(10) Representative Procedure for the Enantioselective
Alkylation (Benzylation) of tert-Butyl 2-Phenyl-5,6-
dihydro-4H-1,3-oxazine-4-carboxylate (7)
To a solution of tert-butyl 2-phenyl-5,6-dihydro-4H-1,3-
oxazine-4-carboxylate (7, 50 mg, 0.2 mmol) in toluene (1.0
mL) were successively added the chiral PTC 16 (11 mg, 0.02
mmol), solid KOH (54.1 mg, 1.0 mmol), and benzyl bromide
(0.1 mL, 1.0 mmol) at 0 °C. The reaction mixture was stirred
for 1 h at 0 °C. After completion of the reaction, the reaction
mixture was diluted with EtOAc (20 mL), and the EtOAc
solution was washed with brine (2 × 5 mL). The organic
solution was then dried over anhyd MgSO4, filtered, and
concentrated in vacuo. The residue was purified by column
chromatography (SiO2; hexanes–EtOAc, 50:1) to afford the
benzylated product 9d (47 mg, 70% yield) as a pale yellow
oil. Because the two enantiomers of 9d were not fully
separated by chiral HPLC, the enantioselectivity was
determined by the chiral HPLC analysis of the
corresponding methyl ester which was prepared from the
hydrolysis of 9d followed by methylation using the excess of
diazomethane. The enantioselectivity was determined as
97% ee [Chiralcel AD-H column, hexanes–2-PrOH (95:5),
flow rate = 1.0 mL/min, 23 °C, 254 nm, tR (R, major) = 5.2
min; tR (S, minor) = 6.8 min, 97% ee]. Absolute configu-
ration was tentatively determined as R based on the absolute
configuration of 9a.
(6) Mahler, S. G.; Serra, G. L.; Antonow, D.; Manta, E.
Tetrahedron Lett. 2001, 42, 8143.
Synlett 2009, No. 4, 671–674 © Thieme Stuttgart · New York